Feasibility study of weekly nanoparticle albumin-bound (nab)-paclitaxel (150 mg/m(2)) followed by 5FU, epirubicin, plus cyclophosphamide (FEC) as neoadjuvant chemotherapy for HER2-negative breast cancer
EUROPEAN JOURNAL OF CANCER(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络